Praziquantel

Drug

Drug Profile

Praziquantel is an oral anthelmintic used for treatment of schistosomiasis and certain liver fluke infections in patients aged one year and older. It is generally administered as short-course same-day divided dosing. Initial U.S. approval was in 1982.

Drug Class
Anthelmintic
Approval Status
FDA approved (initial U.S. approval 1982)
Brand Names
  • \Praziquantel Tablets\
  • Biltricide
Indications
  • \Schistosomiasis due to Schistosoma species\
  • \Clonorchiasis and opisthorchiasis due to liver flukes\

Related News

Related Clinical Trials

NCT ID Title Status Phase
NCT03640377

Praziquantel in Children Under Age 4

COMPLETED PHASE2